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To the Editor: 
Response to Ward Dean: I proudly plead guilty as charged to the concern that in- 
creased support of biomarker research, as it presently is perceived by Dean and others 
like him, will divert funds from my "pet  projects." My pet projects clearly were 
indicated as any untargeted pursuit of mechanistic understanding of established 
phenomena of aging. At least many phenomena of aging now are well established as 
artifactual manifestations of disease, lifestyle, and a plethora of other behavioral, 
sociological, and/or humanistic factors about which biomedical investigators know 
alarmingly too little. In other words, we do not yet have the foggiest notion of what 
biological aging is. 
I have no doubt that our research community possesses the capability to develop the 
means to modify one or more of an eventually established battery of biomarkers. 
However, in the light of the present knowledge base, it seems highly likely that modifi- 
cation of one or more biomarkers only will serve to leave unscathed the more perva- 
sive, underlying afflictions or process(es) of aging. The readily conceded exception to 
my stance applies to those all too few investigators whose primary purpose in 
biomarker research is to utilize homeostatic perturbation as a means to pursue basic 
understanding. 
I readily reiterate the potential importance of any biomarker research, as long as it is 
good research. I also remain in support of the established history that continued pursuit 
of the descriptive at the cost of basic understanding is both less sophisticated and of less 
societal importance. 
Response to Richard Sprott: Sprott is no less a champion of the importance of basic 
research than I am. Our difference seems to focus on the perceived intent of support for 
biomarker research. In order to avoid repetition of my response to Ward Dean, I shall 
limit this response to the issue of NIA funding priorities. 
Perhaps typical of gerontological data, Sprott and I interpret the identical data bases 
differently. In his first of two points on NIA funding priorities, he implies that the 
mandate of NIA has not changed over the years. I, indeed, am one of several inves- 
tigators who perceives that the emphasis of NIA has shifted emphatically in support of 
disease-related research at the expense of investigation of fundamental biological, be- 
havioral, and social processes that are unrelated to disease. In my opinion, there is not 
even a need for me to develop an argument. Instead, I urge interested readers to 
examine publicly available, published program priorties of the NIA since its inception 
and to reach their own conclusions. I concur with Sprott's assertion that the distribu- 
tion of NIA grant support reflects the results of peer review of investigator-initiated 
grant applications, a process for which each of us has great enthusiasm. However, in 
my opinion, he gives far too little credit to the impact of the disease-oriented public 
relations machinery of the NIA among the general research community. 
In his second point, Sprott presents fiscal summaries of NIA grants since 1981 and 
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indicates the absence of trends. In an alternative approach, I chose to examine 
printouts of NIA grant support to each individual investigator. My evaluation of these 
data indicates that NIA support of disease-related research has increased from approx- 
imately 25% to nearly 60% of the increasing extramural budget during the past five 
years, and that nearly all of the new money was invested in disease-related research. 
Such analyses are susceptible to subjective influence. Therefore, I again urge interested 
readers to examine the publicly available information and to reach their own conclu- 
sions. 
This type of interaction is healthy, important and necessary. I continue to have 
enormous appreciation for the support of the basic science community by the NIA. 
However, it is most appropriate to air such differences in opinion with respect to the 
budgetary and intellectual emphases of any federal funding agency, such as they relate 
to research on biomarkers or other aspects of aging. 
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